CIK 0001439222 · Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-01-20 | Hirsch Andrew Chief Financial Officer | Option exercise | +15,000 | 15,000 | ||
| 2019-01-20 | Hirsch Andrew Chief Financial Officer | Option exercise · Performance share unit | −15,000 | 0 | ||
| 2019-01-20 | Hoerter Steven L. Chief Commercial Officer | Option exercise | +15,000 | 15,000 | ||
| 2019-01-20 | Hoerter Steven L. Chief Commercial Officer | Option exercise · Performance share unit | −15,000 | 0 | ||
| 2019-01-20 | Bowden Christopher Chief Medical Officer | Option exercise | +6,265 | 7,189 | ||
| 2019-01-20 | Bowden Christopher Chief Medical Officer | Option exercise · Performance share unit | −6,265 | 0 | ||
| 2018-12-21 | Biller Scott Chief Scientific Officer | Option exercise | +20,500 | $2.34 | $48K | 24,637 |
| 2018-12-21 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −20,500 | 7,218 | ||
| 2018-11-08 | Schenkein David P Chief Executive Officer | Gift | −1,000 | 270,772 | ||
| 2018-11-05 | Biller Scott Chief Scientific Officer | Option exercise | +3,000 | $9.05 | $27K | 53,932 |
| 2018-11-05 | Biller Scott Chief Scientific Officer | Sale | −2,200 | $69.44 | $153K | 51,732 |
| 2018-11-05 | Biller Scott Chief Scientific Officer | Sale | −700 | $70.23 | $49K | 51,032 |
| 2018-11-05 | Biller Scott Chief Scientific Officer | Sale | −100 | $71.42 | $7K | 50,932 |
| 2018-11-05 | Biller Scott Chief Scientific Officer | Option exercise · Stock options (right to buy) | −3,000 | 4,154 | ||
| 2018-10-05 | Biller Scott Chief Scientific Officer | Option exercise | +3,000 | $9.05 | $27K | 53,932 |
| 2018-10-05 | Biller Scott Chief Scientific Officer | Sale | −900 | $68.56 | $62K | 53,032 |
| 2018-10-05 | Biller Scott Chief Scientific Officer | Sale | −979 | $69.47 | $68K | 52,053 |
| 2018-10-05 | Biller Scott Chief Scientific Officer | Sale | −1,100 | $71.05 | $78K | 50,953 |
| 2018-10-05 | Biller Scott Chief Scientific Officer | Sale | −21 | $71.77 | $2K | 50,932 |
| 2018-10-05 | Biller Scott Chief Scientific Officer | Option exercise · Stock options (right to buy) | −3,000 | 7,154 |
Page 56 of 63 · 1,252 trades